Michael Ditiatkovski

633 total citations
14 papers, 476 citations indexed

About

Michael Ditiatkovski is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Michael Ditiatkovski has authored 14 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Michael Ditiatkovski's work include Cholesterol and Lipid Metabolism (6 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and HIV Research and Treatment (2 papers). Michael Ditiatkovski is often cited by papers focused on Cholesterol and Lipid Metabolism (6 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and HIV Research and Treatment (2 papers). Michael Ditiatkovski collaborates with scholars based in Australia, United States and Germany. Michael Ditiatkovski's co-authors include Dmitri Sviridov, Ban‐Hock Toh, Alex Bobik, Nigora Mukhamedova, Peter Kanellakis, A. Bobik, Michael Bukrinsky, Ying Fu, Hann Low and Peter J. Meikle and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cell Metabolism.

In The Last Decade

Michael Ditiatkovski

14 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Ditiatkovski Australia 11 199 160 128 78 67 14 476
Ma Àngels Ortiz Spain 12 90 0.5× 198 1.2× 56 0.4× 100 1.3× 77 1.1× 29 483
Curtis L. Gabriel United States 9 110 0.6× 238 1.5× 35 0.3× 30 0.4× 150 2.2× 20 525
Wieslawa Giermakowska United States 15 108 0.5× 142 0.9× 30 0.2× 207 2.7× 60 0.9× 27 459
Shadi Salloum United States 14 172 0.9× 85 0.5× 30 0.2× 85 1.1× 268 4.0× 25 604
Charles Allen United States 13 92 0.5× 108 0.7× 29 0.2× 39 0.5× 59 0.9× 20 360
Xi Luo China 14 187 0.9× 157 1.0× 42 0.3× 50 0.6× 40 0.6× 25 527
L. Campillo-Gimenez France 11 157 0.8× 267 1.7× 39 0.3× 140 1.8× 92 1.4× 18 583
Christopher Parsons United States 11 166 0.8× 63 0.4× 40 0.3× 40 0.5× 179 2.7× 23 466
Qiujiang Du Canada 10 134 0.7× 71 0.4× 53 0.4× 22 0.3× 75 1.1× 11 308
Masato Ohta Japan 12 289 1.5× 109 0.7× 133 1.0× 6 0.1× 80 1.2× 38 612

Countries citing papers authored by Michael Ditiatkovski

Since Specialization
Citations

This map shows the geographic impact of Michael Ditiatkovski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ditiatkovski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ditiatkovski more than expected).

Fields of papers citing papers by Michael Ditiatkovski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Ditiatkovski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ditiatkovski. The network helps show where Michael Ditiatkovski may publish in the future.

Co-authorship network of co-authors of Michael Ditiatkovski

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Ditiatkovski. A scholar is included among the top collaborators of Michael Ditiatkovski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Ditiatkovski. Michael Ditiatkovski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Low, Hann, Nigora Mukhamedova, Luciano dos Santos Aggum Capettini, et al.. (2020). Cholesterol Efflux-Independent Modification of Lipid Rafts by AIBP (Apolipoprotein A-I Binding Protein). Arteriosclerosis Thrombosis and Vascular Biology. 40(10). 2346–2359. 16 indexed citations
2.
Ditiatkovski, Michael, Nigora Mukhamedova, Dragana Dragoljevic, et al.. (2020). Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction. Journal of Biological Chemistry. 295(38). 13377–13392. 22 indexed citations
3.
Fu, Ying, Denny L. Cottle, Nigora Mukhamedova, et al.. (2020). ABCA12 regulates insulin secretion from β‐cells. EMBO Reports. 21(3). e48692–e48692. 15 indexed citations
4.
Mukhamedova, Nigora, Anh Hoang, Dragana Dragoljevic, et al.. (2019). Exosomes containing HIV protein Nef reorganize lipid rafts potentiating inflammatory response in bystander cells. PLoS Pathogens. 15(7). e1007907–e1007907. 95 indexed citations
5.
Ditiatkovski, Michael, et al.. (2017). Apolipoprotein A-I Mimetic Peptides. Arteriosclerosis Thrombosis and Vascular Biology. 37(7). 1301–1306. 18 indexed citations
6.
Low, Hann, Nigora Mukhamedova, Huanhuan Cui, et al.. (2016). Cytomegalovirus Restructures Lipid Rafts via a US28/CDC42-Mediated Pathway, Enhancing Cholesterol Efflux from Host Cells. Cell Reports. 16(1). 186–200. 44 indexed citations
7.
Ditiatkovski, Michael, Huanhuan Cui, Miroslav Malešević, et al.. (2015). Inhibition of Extracellular Cyclophilins with Cyclosporine Analog and Development of Atherosclerosis in Apolipoprotein E–Deficient Mice. Journal of Pharmacology and Experimental Therapeutics. 353(3). 490–495. 5 indexed citations
8.
Cui, Huanhuan, Michael Ditiatkovski, Yuri V. Bobryshev, et al.. (2014). HIV protein Nef causes dyslipidemia and formation of foam cells in mouse models of atherosclerosis. The FASEB Journal. 28(7). 2828–2839. 44 indexed citations
9.
Ditiatkovski, Michael, Wilissa D’Souza, Jaye Chin‐Dusting, et al.. (2013). An Apolipoprotein A-I Mimetic Peptide Designed with a Reductionist Approach Stimulates Reverse Cholesterol Transport and Reduces Atherosclerosis in Mice. PLoS ONE. 8(7). e68802–e68802. 28 indexed citations
10.
Fu, Ying, Nigora Mukhamedova, Wilissa D’Souza, et al.. (2013). ABCA12 Regulates ABCA1-Dependent Cholesterol Efflux from Macrophages and the Development of Atherosclerosis. Cell Metabolism. 18(2). 225–238. 45 indexed citations
11.
Bukrinsky, Michael, Alexander N. Orekhov, Michael Ditiatkovski, & Dmitri Sviridov. (2013). Cyclophilins in Atherosclerosis: A New Therapeutic Target?. Current Pharmaceutical Design. 19(33). 5904–5908. 3 indexed citations
12.
Kanellakis, Peter, et al.. (2012). A pro-fibrotic role for interleukin-4 in cardiac pressure overload. Cardiovascular Research. 95(1). 77–85. 75 indexed citations
13.
Ditiatkovski, Michael, Ban‐Hock Toh, & Alex Bobik. (2006). Mo-W12:3 Absence of granulocyte macrophage-colony stimulating factor accelerates development of atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis Supplements. 7(3). 33–33. 1 indexed citations
14.
Ditiatkovski, Michael, Ban‐Hock Toh, & Alex Bobik. (2006). GM-CSF Deficiency Reduces Macrophage PPAR-γ Expression and Aggravates Atherosclerosis in ApoE-Deficient Mice. Arteriosclerosis Thrombosis and Vascular Biology. 26(10). 2337–2344. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026